Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Junjie Hang

Clinical trials sponsored by Junjie Hang, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New cocktail of drugs targets Hard-to-Treat pancreatic cancer Results expected May 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1
Sort by
  • New cocktail of drugs targets Hard-to-Treat pancreatic cancer

    Disease control Recruiting now

    This early-phase trial tests a combination of three drugs—regorafenib, toripalimab, and albumin-bound paclitaxel—as a third-line treatment for people with advanced pancreatic cancer that has spread or cannot be removed. The study aims to find the safest dose and see if the combo …

    Phase 1/2 • Sponsor: Junjie Hang • Aim: Disease control

    Last updated Jun 27, 2026 12:34 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space